Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
McKesson
Boehringer Ingelheim
Dow
Harvard Business School

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Litigation Details for Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd. (D. Del. 2016)

See Plans and Pricing

« Back to Dashboard

Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-10-17
Court District Court, D. Delaware Date Terminated 2019-09-13
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand Defendant Referred To Christopher J. Burke
Parties ASTELLAS IRELAND CO., LTD.; ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.; ASTELLAS PHARMA INC.; SAWAI PHARMACEUTICAL CO., LTD.; SAWAI USA, INC.
Patents 6,346,532; 7,342,117; 7,750,029; 7,982,049; 8,835,474; RE44,872
Attorneys Brian J. Sodikoff; Christopher B. Ferenc; Dominick T. Gattuso; Jack B. Blumenfeld; Martin S. Masar , III; Maryellen Noreika
Link to Docket External link to docket
Small Molecule Drugs cited in Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 16 action for patent infringement of United States Patent Nos. 6,346,532 (“the '532 patent”), 7,342,117…claim of U.S. Patent Nos. 6,346,532 (“the '532 patent”), 7,342,117 (“the '117 patent”), 7,982,049…, U.S. Patent No. 6,011,048, U.S. Patent No. 5,451,677, U.S. Patent No. 5,541,197, U.S. Patent No. 5,…the '117 patent”), 7,982,049 (“the '049 patent”), 8,835,474 (“the '474 patent”), and RE44,872…validity and patentability of the '532 patent. A true and correct copy of the '532 patent is attached External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,346,532 B1; 7,342,117 B2; 7,982,049… 13 September 2019 1:16-cv-00954 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Colorcon
Harvard Business School
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.